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Sphingosine 1-phosphate lyase 
ablation disrupts presynaptic 
architecture and function via an 
ubiquitin- proteasome mediated 
mechanism
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The bioactive lipid sphingosine 1-phosphate (S1P) is a degradation product of sphingolipids that are 
particularly abundant in neurons. We have shown previously that neuronal S1P accumulation is toxic 
leading to ER-stress and an increase in intracellular calcium. To clarify the neuronal function of S1P, we 
generated brain-specific knockout mouse models in which S1P-lyase (SPL), the enzyme responsible 
for irreversible S1P cleavage was inactivated. Constitutive ablation of SPL in the brain (SPLfl/fl/Nes) but 
not postnatal neuronal forebrain-restricted SPL deletion (SPLfl/fl/CaMK) caused marked accumulation of 
S1P. Hence, altered presynaptic architecture including a significant decrease in number and density of 
synaptic vesicles, decreased expression of several presynaptic proteins, and impaired synaptic short 
term plasticity were observed in hippocampal neurons from SPLfl/fl/Nes mice. Accordingly, these mice 
displayed cognitive deficits. At the molecular level, an activation of the ubiquitin-proteasome system 
(UPS) was detected which resulted in a decreased expression of the deubiquitinating enzyme USP14 
and several presynaptic proteins. Upon inhibition of proteasomal activity, USP14 levels, expression of 
presynaptic proteins and synaptic function were restored. These findings identify S1P metabolism as a 
novel player in modulating synaptic architecture and plasticity.
S1P is an evolutionarily conserved catabolic intermediate of sphingolipid metabolism that has been suggested to 
regulate crucial functions in the brain including neural development, differentiation and survival1,2. Its deficiency 
resulted in embryonic lethality associated with disturbed neurogenesis including neural tube closure1. On the 
other hand its accumulation turned out to be neurotoxic leading to neuronal death3,4. Alternatively, S1P is pro-
posed as a neuroprotective factor that is lost early in Alzheimer pathogenesis5. These controversial findings point 
to a tight regulation of S1P levels in the brain. However, reports regarding the function of enzymes involved in 
S1P metabolism are also controversial. There are two isoforms of sphingosine kinases (SK1 and SK2) that generate 
S1P6. Presynaptic SK1-derived S1P was reported to promote neurotransmitter release in hippocampal neurons7 
and C. elegans8, while studies in human and rodent brain suggest that SK2 is particularly important in neurons9,10. 
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However, the major regulator of intracellular S1P levels is S1P-lyase (SPL). It catalyses the irreversible cleavage of 
S1P to hexadecenal and ethanolamine phosphate, the final step of sphingolipid catabolism11.
Others and we have shown that loss of SPL activity results in tissue-dependent accumulation of S1P, sphin-
gosine and other sphingolipid intermediates3,12,13. Intriguingly, SPL-deficiency in neurons causes a predominant 
S1P accumulation and to a lesser degree, its metabolic precursor sphingosine with no significant alterations in 
ceramide, sphingomyelin and glycosphingolipids13. S1P accumulation in SPL-deficient neurons was associated 
with increased cytosolic calcium levels4 and ER-stress13, which mediated apoptotic neuronal death4. Based on 
these findings and due to early postnatal death of systemic SPL knockouts13, we assumed that brain-specific abla-
tion of SPL might serve as a tool to clarify the role of neuronal S1P. We therefore generated two mouse models, 
one with developmental neural-specific, and one with postnatal neuronal forebrain-targeted ablation of SPL and 
explored the consequences on synaptic plasticity. Our results strongly suggest an involvement of sphingolipid 
metabolism in maintaining presynaptic nerve terminal architecture and functions leading to cognitive deficits. 
We further show that S1P accumulation is essential for the assessed elevation of ubiquitin-proteasome system 
(UPS) which is responsible for the decreased expression of several presynaptic proteins and of the deubiquitinat-
ing protease USP14. The latter was shown to play a critical role in synaptic plasticity and its loss is associated with 
several physiological impairments in the central nervous system14.
Results
Generation of two tissue-specific SPL knockout mouse models. Mice in which exons 9/10 
and 12/13 encoding for the binding site of the SPL cofactor pyridoxalphosphate (PLP) were flanked by loxP 
sites (floxed, Sgpl1flox/flox) were crossbred with the nestin-Cre transgenic mouse line Nes-Cre1 in which Cre-
recombinase expression is under the control of the nestin promoter15. Siblings expressing both, loxP sites and 
Cre-recombinase (SPLfl/fl/Nes) exhibited a considerable reduction in the brain on transcriptional and protein level 
(Fig. 1a,b). The residual mRNA amounting to 10 ± 4% is most probably derived from non-neural cells devoid of 
an active nestin promoter15. Accordingly, a slight protein band was also detectable (Fig. 1b). In contrast to sys-
temic SPL deletion, mice lacking SPL only in neural tissue (SPLfl/fl/Nes) exhibit a rather unremarkable phenotype 
and their lifespan is comparable to that of their wild type littermates, thus representing a promising model to 
analyze the role of SPL in brain physiology. Post-natal forebrain-specific deletion of SPL was achieved by crossing 
the floxed SPL mice (Sgplflox/flox) with a transgenic Cre-expressing line, driven by calcium/calmodulin-dependent 
protein kinase II α subunit (CaMKII-Cre)16. As expected the resulting SPLfl/fl/CaMK mice showed reduced SPL 
expression only in cortex and hippocampus but not in cerebellum (Fig. 1).
SPL ablation causes S1P accumulation in brains of SPLfl/fl/Nes but not SPLfl/fl/CaMK mice. Consistent 
with earlier findings in primary cultured cerebellar neurons generated from mice with systemic SPL deletion13, 
neural-targeted depletion of SPL resulted in a considerable accumulation of S1P and its metabolic precursor 
sphingosine with no changes in ceramide and sphingomyelin in brains of SPLfl/fl/Nes mice (Fig. 1c). Postnatal neu-
ronal forebrain-restricted ablation of SPL did not cause accumulation of any sphingolipid either in hippocampi 
(forebrain domain) or cerebella of SPLfl/fl/CaMKmice. Obviously, the residual SPL expression in other than CaMKII 
expressing cells (Fig. 1a) is sufficient to prevent accumulation of S1P in this mouse model. Hence, only SPLfl/fl/Nes 
mice were investigated further.
SPLfl/fl/Nes mice exhibit deficits in spatial learning, memory and motor coordination. Based on 
the neurotoxic effects of S1P reported earlier4, we first assessed whether neuronal S1P accumulation affects cog-
nitive skills and motor coordination of SPLfl/fl/Nes mice. First we analysed exploratory activity in an open field and 
found no significant difference in the distance covered by control and SPLfl/fl/Nes mice indicating that locomo-
tor activity is not affected (Fig. 1d). A cognitive test of object placement recognition showed clear impairments 
of hippocampal spatial learning and memory in SPLfl/fl/Nes mice (Fig. 1e). In addition, motor coordination and 
balance with the accelerating rotarod thought to involve cerebellar functions revealed significant impairments 
in SPLfl/fl/Nesmice (Fig. 1f). Thus SPL ablation in neurons is associated with significant behavioural abnormali-
ties. Hence we conducted further experiments in cerebellum and hippocampus. We concentrated on performing 
physiological and morphological studies mainly in the CA1 region of the hippocampus and biochemical studies 
in part in cerebellar neurons.
Altered presynaptic morphology in hippocampal CA1 region of SPLfl/fl/Nes mice. Based on the 
observed behavioural abnormalities and our previous results on S1P neurotoxicity4, we tested whether brains 
of SPLfl/fl/Nes mice exhibit neuronal loss. In a first straight forward approach a neuron-specific nuclear protein 
(NeuN) immunohistochemical staining of coronal brain sections was performed. Although we did not observe 
massive neuronal loss, closer quantitative examination of brain sections revealed a reduced thickness of the den-
tate gyrus in SPLfl/fl/Nesmice (suppl. Fig. 1). These gross irregularities in the hippocampal region prompted us to 
analyse the hippocampal morphology in more detail.
We first assessed the subcellular morphology of asymmetric (excitatory) synapses in the hippocampal CA1 
region in SPLfl/fl/Nesmice.
Analysis of ultrathin sections revealed a significant decrease in number and density of synaptic vesicles in 
nerve terminals from SPLfl/fl/Nesmice compared to controls (Fig. 2a). Density of synaptic vesicles (SVs) localized 
in the area 300 nm from the border of the active zone was decreased in SPLfl/fl/Nesmice compared to controls 
(controls: 340.3 ± 12.3; SPLfl/fl/Nesmice: 129.1 ± 7.3 N/μ m2; P < 0.0001) (Fig. 2b). The reduction was also evident 
in each of 100 nm steps from the border of the active zone, indicating that the number of SVs is reduced not only 
in the reserve pool, but also in the pool proximal to the active zone. Unexpectedly, the number of vesicles asso-
ciated with the presynaptic membrane per μ m2 of the active zone at rest was not reduced significantly (controls: 
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Figure 1. Brain targeted knock-down of SPL and its impact on sphingolipid content and behaviour. SPL 
expression was assessed in the indicated brain domains of 6 weeks old mice of the indicated genotype by (a) 
qRT-PCR (unpaired t-test, P < 0.0001) (b) Western blotting and quantification (unpaired t-test, P < 0.0001) as 
described in the Methods section (c) Sphingolipids from the cerebellum and the hippocampus of mice at the 
indicated age and genotype were determined by LC/MS/MS as described in the Methods section. Sphingosine 
1-phosphate (S1P) and sphingosine (Sph) increased considerably already after 9 weeks in brains of SPLfl/fl/Nes but 
not SPLfl/fl/CaMK mice. Bars represent means ± SEM (n ≥ 3; two-way ANOVA, PS1P,h6w = 0.041, PS1P,h12m = 0.0458, 
PS1P,c6w = 0.041, PS1P,c12m = 0.0458, PSph,h6w = 0.0326, PSph,h12m = 0.0284, PSph,c6w = 0.0326, PSph,c12m = 0.0284). 
The amount of all other lipids determined including ceramides did not change upon SPL knockdown (not 
shown). (d) Open field test: exploratory locomotor activity is expressed as the distance covered during 20 min. 
(e), Object placement recognition test: shown is the exploration time of the objects in the novel and familiar 
location (two-way ANOVA, P = 0.0265) and the discrimination index, represented by the normalized ratio 
of time spent with the object placed in the novel area and the object in the familiar area (unpaired t-test, 
P = 0.0097). (f) Latency to fall from the accelerating rotarod (two-way ANOVA, P < 0.0001).
www.nature.com/scientificreports/
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Figure 2. Subcellular morphology of asymmetrical synapses in CA1 region of murine hippocampus 
following ablation of SPL. Representative electron micrographs of hippocampal synapses from controls (n = 3) 
and SPLfl/fl/Nesmice (n = 3) (a). sv, synaptic vesicles, d, dendritic spines, e, endosomal profile, ccv, clathrin coated 
vesicle, m, mitochondrion. Thick arrows indicate synaptic contacts. (b) bar graph showing average SV density 
within 100, 200, and 300 nm regions from the border of the active zone; (n = 62 synapses from 3 animals; 
***P < 0.0001, two-tailed t-test). (c) frequency distribution of SV diameters from CA1 presynaptic boutons 
from control and SPLfl/fl/Nesmice, mean ± SEM, 36.0 ± 0.3 vs 30.3 ± 0.2, n = 460; P < 0.0001, two-tailed t-test). 
Solid lines represent Gaussian fits for each distribution. (d) expression of dynamin-1 in hippocampal lysates of 
control and SPLfl/fl/Nesmice (P = 0.0003, two-tailed t-test).
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Figure 3. Electrophysiology of Schaffer collateral synapses in CA1 region of murine hippocampus 
with ablation of SPL. (a) mEPSC frequency is significantly reduced and (b) mEPSC amplitude significantly 
increased in SPLfl/fl/Nesslices compared to controls. Cumulative frequencies of occurrence of mEPSC frequencies 
and mEPSC amplitudes are plotted. (b) Inset shows examples of mEPSC traces (black: control; red: SPLfl/fl/Nes),  
lower traces are normalized in amplitude. (c) normal basal synaptic transmission as shown in the input-
output curves. (d) PPF is significantly reduced at Schaffer collateral synapses from SPLfl/fl/Nes mice compared 
to controls. Ratios of the initial slopes of fEPSP pairs are plotted. Inset shows example traces at 40 ms stimulus 
interval (black: control; red: SPLfl/fl/Nes). (e) LTP recorded in the hippocampal CA1 region after high frequency 
stimulation (100 Hz, 1 s) of Schaffer collaterals in control and SPLfl/fl/Nes slices is unchanged. fEPSP slopes are 
expressed as percentage of change from baseline recordings (taken to be 100%) and plotted against time.  
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115.4 ± 48.2 and SPLfl/fl/Nesmice: 98.5 ± 38.0; P = 0.345; n = 28 synapses; two-tailed t-test). This result suggests that 
once available SVs can be efficiently recruited to sites of release. Further, the diameter of SVs in SPLfl/fl/Nesmice was 
significantly larger compared to controls (Fig. 2c). Similar findings were observed for mossy fiber synapses in CA3 
region (suppl. Fig. 2). The number of clathrin-coated endocytic intermediates was significantly increased in nerve 
terminals with ablated SPL as compared to controls (controls: 0.13 ± 0.09 and SPLfl/fl/Nesmice: 1.77 ± 0.35 and; 
P < 0.001; n = 62 synapses; two-tailed t-test). An increased expression of dynamin was also observed in SPLfl/fl/Nes 
mice (Fig. 2d). No significant difference in the length of the active zone was found in synapses from SPLfl/fl/Nes and 
controls (0.23 ± 0.01 and 0.24 ± 0.01, P = 0.224; n = 62; two-tailed t-test).
Spontaneous mEPSCs are altered in SPLfl/fl/Nesmice. To determine whether the changes in vesicle size 
and number were also reflected in the properties of the spontaneous release, we measured mEPSCs in pyramidal 
cells in the CA1 region. The frequency of the spontaneous events in SPLfl/fl/Nesmice (Fig. 3a) was significantly 
reduced (P < 0.001) while the current amplitude (Fig. 3b) was significantly increased (P < 0.001). The latter 
finding is in line with the observation of larger synaptic vesicles in SPLfl/fl/Nesmice (Fig. 2c). Current kinetics of 
mEPSCs were unchanged in SPLfl/fl/Nesmice compared to controls (Fig. 3b inset).
SPLfl/fl/Nesmice exhibit a reduction in paired pulse facilitation (PPF). Based on the observed 
alterations in synaptic morphology of SPLfl/fl/Nesmice, we next assessed the physiological consequences of S1P 
accumulation on synaptic plasticity in hippocampal CA1 region. Dendritic field potential recordings in acute 
hippocampal slices from SPLfl/fl/Nesmice revealed normal basal synaptic transmission (Fig. 3c), but exhibited a 
significant reduction in PPF at Schaffer collateral synapses between 2 to 12 months of age (Fig. 3d). In con-
trast, induced long-term potentiation (LTP) was not altered in SPLfl/fl/Nesmice within this age range (Fig. 3e). 
Because the amount of PPF is normally inversely related to initial release probability17,18 the possibility exists that 
the decrease in PPF in SPLfl/fl/Nesmice is derived from an increase in initial release probability. To assess initial 
release probability we measured the rate of block of NMDA receptors by the use-dependent blocker MK-80119. 
An increase in the release probability would cause an increase in the rate of block. No differences in the rate of 
block by 40 μ M MK-801 were observed using single pulse stimulation in SPLfl/fl/Nes mice compared to control 
animals (Fig. 3f). The initial release probability in SPLfl/fl/Nesmice therefore seems to be unaltered. Using facilitated 
pulses (3 pulses, 100 Hz) the rate of block by MK-801 was reduced by ~300% (Fig. 3g), indicating a lower release 
probability of facilitated responses. This suggests that the observed decrease in PPF is due to a reduction in the 
release probability of the second pulse in SPLfl/fl/Nes mice compared to control mice.
Altered expression of presynaptic proteins in SPLfl/fl/Nesmice. Next, we aimed to identify the molecu-
lar mechanism underlying the observed alterations in synaptic morphology and function in SPL-deficient brains. 
First we assessed whether the reduced number of synaptic vesicles is also reflected in the expression of presynap-
tic proteins. We found that in hippocampi as well as in cultured cerebellar neurons of SPLfl/fl/Nesmice the expres-
sion of the presynaptic markers Bassoon and Synapsin-1 as well as the SNARE-proteins syntaxin and VAMP2 and 
the major synaptic vesicle protein synaptophysin was significantly decreased (Fig. 4a–e). However, the expression 
of other presynaptic proteins including synaptotagmin 1, piccolo, SNAP25, Munc18 and NCS-1 was not affected 
(Suppl. Fig. 4a–e). The expression of the post-synaptic marker PSD-95 (Fig. 4f) and other proteins including 
IDE (insulin degrading enzyme) and GAP-43 (Suppl. Fig. 4f,g) was not affected in SPLfl/fl/Nesmice. Since S1P was 
shown to modulate the activity of histone deacetylases20, we checked whether the decreased expression of pre-
synaptic proteins occurred at transcriptional level. Yet, no changes in transcript amounts were found in brains 
of SPLfl/fl/Nesmice (Fig. 4g). In cultured cerebellar neurons of SPLfl/fl/Nesmice, reduction in presynaptic marker 
proteins Bassoon and synaptophysin were even more pronounced (Fig. 4h,i).
The ubiquitin-proteasomal system is up-regulated in SPLfl/fl/Nesmice. As many presynaptic proteins 
are known to be degraded by the UPS21,22, we next assessed protein ubiquitination and proteasomal activity in 
SPLfl/fl/Nes brains. The amount of ubiquitinated proteins was indeed considerably elevated in brains of SPLfl/fl/Nes 
mice compared to the respective age matched controls (Fig. 5a). Moreover, augmented protein ubiquitination 
was associated with increased proteasomal activity (Fig. 5b). In addition we showed that the presynaptic protein 
synapsin, under-expressed in SPLfl/fl/Nes mice was indeed included in the ubiquitinated protein fraction (Fig. 5c). 
Surprisingly, we obtained 3 clear-cut bands and not the typical ubiquitin smear indicating that three different 
ubiquitinated species of synapsin (corresponding most likely to one, two and six ubiquitin units) are predominant 
in this fraction.
The proteasome-associated deubiquitinating enzyme USP14 on one hand is functionally coupled with pro-
teasomal activity and on the other hand a critical regulator of synaptic plasticity14. We therefore studied the 
expression of USP14 at protein and mRNA level in SPLfl/fl/Nesmice. As depicted in Fig. 5d the expression of USP14 
was considerably reduced in hippocampi of SPLfl/fl/Nesmice. However, there were no significant differences in the 
amount of the respective transcripts (Fig. 5e). On the other hand USP14 was included in the highly ubiquitinated 
(f) blocking rate of the NMDA responses by 40 μ M MK-801 does not significantly vary between control and 
SPLfl/fl/Nes synapses. Results are displayed as 3 point bins. (g) blocking rate of the NMDA responses elicited by 
short trains (3 pulses, 10 ms interval, 0.05 Hz) is slower at SPLfl/fl/Nes synapses compared to controls. Results 
are displayed as 3 point bins. (a,b) n: mEPSCs/mice, control: 4038/6, SPLfl/fl/Nes: 3886/6; data in c-g represent 
means ± SEM; c, n: slices/mice, control: 12/3, SPLfl/fl/Nes: 11/3; (d) n: slices/mice, control: 30/10, SPLfl/fl/Nes: 48/16; 
e, n: slices/mice, control: 15/5, SPLfl/fl/Nes: 19/6; (f) n: neurons/mice, control: 5/4, SPLfl/fl/Nes: 5/4; (g) n: neurons/mice, 
control: 6/4, SPLfl/fl/Nes: 6/5; unpaired t-test, ***P < 0.0001.
www.nature.com/scientificreports/
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protein fraction, suggesting that its decreased expression could be due to its degradation by the proteasome 
(Fig. 5f).
Proteasome inhibition restores PPF as well as expression of USP14 and calcium chelation nor-
malizes proteasomal activity. To test whether slowing protein degradation would restore PPF in the 
hippocampus of SPLfl/fl/Nesmice we treated the hippocampal slices with the proteasome-specific inhibitor epox-
omicin for 5 h, restoring PPF at Schaffer collateral synapses in SPLfl/fl/Nesmice with no significant effect in con-
trols (Fig. 6a). Similarly, the decreased expression of USP14 and the SNARE-proteins syntaxin1 and VAMP2 was 
restored upon treatment with epoxomicin (Fig. 6b–d). Restoration of presynaptic proteins was also recapitulated 
in cultured cerebellar neurons from SPLfl/fl/Nesmice (suppl. Fig. 3a,b). As calcium is a potential inducer of the 
UPS23, and we have shown earlier that S1P accumulation induces calcium release from the ER, the effect of 
calcium chelation on UPS was assessed. Indeed addition of BAPTA-AM completely re-established proteasomal 
activity in neurons derived from SPLfl/fl/Nes mice (Fig. 6e).
Discussion
Here we show that neural-targeted ablation of SPL and the consequent accumulation of S1P and sphingosine 
leads to behavioural, morphological, physiological and molecular abnormalities. Precisely, alterations in pre-
synaptic architecture and short term plasticity were accompanied by a calcium mediated elevation of the UPS 
and hence reduced expression of several synaptic proteins. The inhibition of proteasomal activity restoring both 
synaptic plasticity and protein expression suggests the UPS as a possible link connecting sphingolipid metabolism 
and presynaptic pathology.
Synaptic pathology has been acknowledged as a key early event in neurodegeneration, and presynaptic ter-
minal changes during ageing and neurodegeneration have been reported24,25. However, the detailed mechanisms 
connecting sphingolipid metabolism to synaptic dysfunction remain poorly understood and the existing reports 
on the connection between S1P and sphingosine and synaptic function are rather contradictory8,26–29. Earlier 
reports argue for a positive role of S1P in synaptic transmission8,27–29. Kanno et al.29 have shown that exogenously 
applied S1P to hippocampal slices led to an increase in the rate of mEPSCs and further demonstrated that SK1 
knockout mice had impaired LTP along with poor performance in Morris water maze test. In contrast, a recent 
report demonstrated a repressive effect of S1P signalling on synaptic plasticity26. Consistently, our results argue 
Figure 4. Expression of presynaptic proteins is reduced in SPLfl/fl/Nes mice. (a–f) Protein amounts were 
assessed by immunoblotting (unpaired t-test, PBassoon = 0.0002, PSynapsin-1 < 0.0001, Psyntaxin 1 = 0.0157, 
PVAMP2 = 0.0048, PSynaptophysin = 0.0099), and (g) transcript amounts were determined by qRT-PCR in hippocampi 
of 6-month-old mice. Immunostaining of the presynaptic marker proteins (h) Bassoon and (i) synaptophysin in 
cerebellar granule cells after 2 weeks in culture (unpaired t-test, PBassoon < 0.0001, PSynaptophysin = 0.0034). F-actin 
(red), bassoon and synaptophysin (green).
www.nature.com/scientificreports/
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in favour of S1P and sphingosine accumulation leading to perturbations in synaptic morphology and function. 
Although no changes in LTP were evident our mice exhibited significant learning deficits. Obviously, like shown 
in earlier studies defects in short term plasticity are sufficient to cause profound impairments in learning30,31. 
Hence S1P can be viewed as a double edged sword wherein, despite its importance in normal cellular functions, 
both decrease and increase of the lipid beyond a threshold might affect cellular functions.
The alterations in synaptic transmission observed in the present study were accompanied by morphological 
changes of hippocampal synapses. Vesicle pools were largely reduced (60%) and single vesicles were increased 
in diameter. Consistent with the latter findings, mEPSCs in SPLfl/fl/Nes mice were increased in amplitude and 
occurred at lower frequency compared to control mice. Analysis of mEPSCs revealed no differences in kinetics 
for current activation and decay between control and SPLfl/fl/Nes animals suggesting no change in postsynaptic 
AMPA receptors. Similarly, decay kinetics of evoked postsynaptic currents (eEPSCs) were identical between the 
first and last eEPSC within a high-frequency stimulus train (data not shown) suggesting that NMDA receptors 
were also not affected. This is supported by the findings from experiments on initial release probability where 
Figure 5. Ablation of SPL leads to an elevation of UPS activity and a decreased expression of USP14. 
Experiments were performed in brains of SPLfl/fl/Nes mice at the indicated ages. (a) Age-dependent increase 
of ubiquitinated proteins (two-way ANOVA, Pgenotype = 0.0058, Ptime = 0.0284). (b) increase of proteasomal 
activity (two-way ANOVA, Pgenotype = 0.0058). (d) expression of USP14 (two-way ANOVA, Pgenotype < 0.0001).
(e) transcript levels of USP14. (c,f) immunoprecipitation of ubiquitinated (Ub) proteins followed by Western 
blotting of synapsin-1 and USP14 (unpaired t-test, PSynapsin-1 = 0.0239, PUSP14 = 0.0231).
www.nature.com/scientificreports/
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Figure 6. Proteasome inhibition restores paired-pulse facilitation (PPF), USP14 as well as SNARE- proteins 
and calcium chelation normalizes proteasomal activity. Hippocampal slices from control and SPLfl/fl/Nes mice 
were incubated in the absence (black traces) or presence (red traces) of 15 μ M epoxomicin (Epoxo) for 5 h. (a) 
PPF n: slices/mice, control: 15/6, SPLfl/fl/Nes: 16/7 (two-way ANOVA, Pgenotype = 0.0009, PEpoxo = 0.0003). (b–d) 
immunoblotting of USP14 and SNARE-proteins (two-way ANOVA, PUSP14,genotype = 0.0125, PUSP14,Epoxo = 0.0251, 
PSyntaxin 1,genotype = 0.0315, PSyntaxin 1,Epoxo = 0.0138, PVAMP2, genotype = 0.0390, PVAMP2,Epoxo = 0.0426). (e) Neurons were 
incubated in the presence of the calcium chelator BAPTA-AM (5 μ M, 1 h) and proteasomal activity was assessed 
(two-way ANOVA, P = 0.0003).
www.nature.com/scientificreports/
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NMDA receptor mediated EPSCs were unaltered in SPLfl/fl/Nesmice compared to controls. However, we cannot 
rule out the possibility that changes in the properties of postsynaptic receptors might contribute to the observed 
differences in spontaneous mEPSCs.
Normally, a reduction in PPF is accompanied by an increase in initial release probability17,18. However, there 
are also examples of changes in PPF that are not caused by changes in the initial release probability32–35. In the 
study by Walters et al.35 a reduction in the deubiquitinating enzyme USP14 impairs PPF without changing the 
initial release probability. Instead the loss of USP14 led to a large reduction in the number of presynaptic vesicles. 
Such a mechanism might also contribute to the synaptic changes observed in SPLfl/fl/Nesmice. This is supported by 
our finding that PPF in SPLfl/fl/Nesmice was restored to control levels after inhibition of USP14 protein degradation.
Note that based on the known effects of increased calcium levels on endocytosis36,37 an increased recycling 
and delivery of vesicles to release sites may be expected. In agreement with this, no difference in the number of 
“docked” vesicles was detected in synapses at rest. Moreover, an increased level of dynamin-1 and an increased 
number of coated endocytic vesicles were observed in the SPL-deficient brains. Additional effects of endocytosis 
and calcium on the increased size of synaptic vesicles in hippocampi of SPLfl/fl/Nesmice remain unclear.
Deletion studies have helped to identify presynaptic proteins which are essential for synaptic function and 
integrity. Removal of such key proteins often leads to impaired neurotransmitter release, changes of the vesicle 
pools or cytomatrix at the active zone. However, in some cases the loss of function can be compensated by other 
presynaptic proteins38–40. On analyzing the levels of selected key proteins involved in different stages of the vesicle 
cycle, we found that several of these proteins were reduced in SPLfl/fl/Nesmice. Since we neither observed a change 
in synaptic strength nor morphological changes in the active zone we conclude that the observed reductions 
in presynaptic proteins do not underlie or at least are not sufficient41 to cause the observed changes in synaptic 
transmission in SPLfl/fl/Nesmice. However, at the structural level a reduction in number of synaptic vesicles in the 
pool has been reported in synapsin-1 and synapsin triple-knockout mice42,43. Accordingly, a profound reduction 
in number of vesicles has been reported also in the current study. A redistribution of synapsin-1 has been recently 
reported following application of S1P in nanomolar concentration to synapses44 thus suggesting that this protein 
might be a direct target of S1P action. On the other hand, restoration of proteasomal activity and hence expres-
sion of USP14 and presynaptic proteins rescued PPF in SPLfl/fl/Nesmice.
In line with our findings in SPLfl/fl/Nes mice, USP14 was shown to regulate hippocampal short-term plasticity 
and vesicle number35. In addition to regulatory effects of USP14 on synaptic activity in ataxia mice45 a protec-
tive role for the same against Huntington’s cell aggregates has been implicated46. We propose the degradation of 
USP14 by UPS as the underlying molecular mechanism responsible for the physiological and behavioural impair-
ments observed (Fig. 7). Localised in the 19 S regulatory subunit of the proteasome, USP14 has been proposed 
as a negative modulator of proteasome-mediated degradation47. Nevertheless we are aware of the complexity of 
USP14 functions in the CNS48. The substrate specificity of USP14 has been documented before47. In line with 
this we also observed reduced expression of some presynaptic proteins, whereas other proteins were unchanged. 
The increased expression of dynamin-1 might be explained by other mechanisms like its direct interaction with a 
chaperone complex reported to stabilize its level at the synapse49.
Thus our results indicate a crucial role of proteasomal activity and hence deregulated protein degradation in 
altered synaptic transmission induced by SPL deficiency. Although, we cannot conclusively pinpoint the exact 
underlying molecular mechanism, our results, which are in line with recent findings of Walters et al.35, suggest 
that quenching of USP14 by the elevated UPS activity might be the central switch that propagates the observed 
synaptic pathology in SPLfl/fl/Nesmice. Since presynaptic dysfunction might be an early pathogenic event in 
Figure 7. Schematic of proposed molecular mechanism linking SPL activity, synaptic transmission 
and cognitive skills. S1P accumulation upon SPL deletion causes elevation of cytosolic Ca2+, which in turn 
increases the activity of the ubiquitin-proteasomal system (UPS). As a consequence the expression of the 
proteasome-associated deubiquitinating enzyme USP14 and of some presynaptic proteins is reduced, thereby 
impairing presynaptic plasticity coupled to behavioural and motor coordination deficits. PPF, paired pulse 
facilitation; SV, synaptic vesicle.
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neurodegeneration50, our findings could have important implications for diseases where S1P analogues are used 
as disease modifying therapies.
Methods
Mice. All animal experiments were conducted in accordance with the guidelines of the Animal Care 
Committee of the University of Bonn (LANUV NRW, Az. 87-51.04.2011.A049).
The Sgpl1flox/flox lines were generated as recently described51. Sgpl1flox/flox mice, harbouring “floxed” exons 
10–12 on both Sgpl1 alleles were crossbred either with mice expressing nestin-Cre transgene or the calcium/
calmodulin-dependent protein kinase II α subunit-Cre transgene (CaMKII-Cre). Thus SPLfl/fl/Nes and SPLfl/fl/CaMK 
mice in which “floxed” exons are excised by Cre recombinase were obtained.
Ethical statement. All animal experiments were conducted in accordance with the guidelines of the Animal 
Care Committee of the University of Bonn. The experimental protocols were approved by Landesamt für Natur, 
Umwelt und Verbraucherschutz Nordrhein-Westfalen (LANUV) (LANUV NRW, Az. 87-51.04.2011.A049).
Antibodies. Monoclonal antibodies against synapsin-1, synaptophysin, PSD95, Bassoon, SNAP25, 
VAMP2 and ß-Actin (8H10D10), anti synaptotagmin1 polyclonal antibody, secondary antibodies including 
HRP-linked anti-rabbit and anti-mouse IgG, and fluorescent secondary antibodies (anti-rabbit IgG (H+ L), 
F(ab’)2 Fragment-Alexa Fluor 488 conjugated and anti-mouse IgG (H+ L), F(ab’)2 Fragment-Alexa Fluor 555 
conjugated) were from Cell Signaling Technology (Cambridge, UK). Anti-piccolo polyclonal serum was from 
Synaptic Systems (Göttingen, Germany), anti-syntaxin1a polyclonal antibody from Abcam (Cambridge, UK), 
anti-ubiquitinylated proteins, clone FK2 (mouse monoclonal IgG1) from Millipore (Darmstadt, Germany), rabbit 
polyclonal anti USP14 was from Thermo Fisher (Rockford, IL, USA).
Cell culture. Granular cells were cultured from the cerebella of 6-day-old mice as previously described52. 
Briefly, neurons were isolated by mild trypsinization (0.05%, w/v) and dissociated by passing them repeat-
edly through a constricted Pasteur pipette in a DNase solution (0.1%, w/v). The cells were then suspended in 
Dulbecco’s Modified Eagle’s Medium containing 10% heat-inactivated horse serum supplemented with 100 units/
ml penicillin and 100 mg/ml streptomycin and plated onto 15 mm sterile glass coverslips placed in 6-well plates, 
35 mm in diameter, and precoated overnight at 37 °C with 0.01 mg/ml of Poly-L-Lysin dissolved in 1 x PBS 
(5 × 105 cells/well). After 10 days in culture cells were used for experiments as indicated.
Lipid extraction and quantification. Lipid measurements were performed according to an established 
protocol using liquid chromatography coupled to triple-quadrupole mass spectrometry (LC/MS/MS)53. Tissue 
samples were homogenized using the Stomacher Model 80 MicroBiomaster Blender (Seward) in 5 ml PBS after 
addition of C17-base sphingosine (Sph), C17-base S1P, C17-base sphingomyelin, and C15-base ceramide (Cer) 
as internal standards (300 pmol/sample, Avanti Polar Lipids). One ml supernatants were transferred into glass 
centrifuge tubes and mixed with 200 μ l of 6 N hydrochloric acid and 1 ml methanol, and vigorously vortexed 
for 5 min in the presence of 2 ml chloroform. Aqueous and chloroform phases were separated by centrifugation 
for 3 min at 1900× g, and the lower chloroform phase was transferred into a new glass centrifuge tube. After a 
second round of lipid extraction with additional 2 ml chloroform, the two chloroform phases were combined 
and vacuum-dried at 50 °C for 50 min using a vacuum concentrator. The extracted lipids were dissolved in 100 μ l 
methanol/chloroform (4:1, v/v) and stored at − 20 °C. Detection was performed with the QTrap triple-quadrupole 
mass spectrometer (ABSciex, Concord, Canada) interfaced with the 1100 series chromatograph (Agilent, Santa 
Clara, California, USA), the Hitachi Elite LaChrom column oven (VWR, Radnor, Pennsylvania, USA), and the 
Spectra System AS3500 autosampler (Thermo Separation Products). Positive electrospray ionization (ESI) LC/
MS/MS analysis was used for detection of sphingosine 1-phosphate (S1P), Sph, and sphingomyelin (SM), posi-
tive atmospheric pressure chemical ionization (APCI) for detection of Cer, hexosylcerebrosides (GalCerBr), and 
cholesterol (Chol). Multiple reaction monitoring (MRM) transitions were as follows: S1P m/z 380/264, C17-S1P 
m/z 366/250, Sph m/z 300/282, C17-Sph m/z 286/268, C15-Cer m/z 524/264 (positive mode) 522/266 (nega-
tive mode), C16-Cer m/z 538/264, C18-Cer m/z 566/264, CerBr (24:1) m/z 810/264, SM (16:0) m/z 703/184, 
SM (18:0) m/z 731/184, SM (17:0) m/z 717/184, Chol m/z 369/161. Liquid chromatographic resolution of 
all analytes was achieved using a 2 × 60 mm MultoHigh C18 reversed phase column with 3 μ m particle size 
(CS-Chromatography Service). The column was equilibrated with 10% methanol and 90% of 1% formic acid in 
H2O for 5 min, followed by sample injection and 15 min elution with 100% methanol with a flow rate of 300 μ 
l/min. Standard curves were generated by adding increasing concentrations of the analytes to 300 pmol of the 
internal standard. Linearity of the standard curves and correlation coefficients were obtained by linear regression 
analyzes. Data analyzes were performed using Analyst 1.6 (ABSciex, Concord, Canada).
Reverse transcription and real-time PCR. Total RNA was extracted from brains using RNeasy Mini 
Kit (QIAGEN, Hilden, Germany), and treated with RNase-free DNase (QIAGEN) according to the man-
ufacturer’s instructions. Reverse transcription of 1 μ g of total RNA was performed using the First Strand 
cDNA Synthesis Kit (ProtoScript II, New England BioLabs, Frankfurt am Main, Germany). The primers for 
real-time PCR were designed using the online tool from Life Technologies „Custom Primers - OligoPerfect™ 
Designer” and obtained from the same company. They are listed as follows: name: forward primer, reverse 
primer: bassoon: 5′ TACACCGCTCTTCCTGCTCT3′ , 5′ TGTACTCGCTGCCAGACTTG3′ ; synapsin-1: 5′ 
TCCAGAAGATTGGGCAGAAC3′ , 5′ TCAGACATGGCAATCTGCTC3′ ; synaptophysin: 5′ AGTACCC 
ATTCAGGCTGCAC3′ , 5′ CCGAGGAGGAGTAGTCACCA3′ ; syntaxin 1: 5′ GAACAAAGTTCGCTCCAAGC3′ , 
5′ ATTCCTCACTGGTCGTGGTC3′ ; vamp2: 5′ TGACGGTTCCCATCACCTCTC3′ , 5′ CTGTGGGGTTTGCTTT 
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TGTT3′ ; psd-95: 5′ TTTCTCCCACACACATTCCA3′ , 5′ ACCTTCCACTCATGCAAACC3′ ; s1p-lyase: 
5′ TTTCCTCATGGTGTGATGGA3′ , 5′ CCCCAGACAAGCATCCAC3′ ; β -actin: 5′ CCACAGCTGA 
GAGGGAAATC3′ , 5′ TCTCCAGGGAGGAAGAGGAT3′ ; 12.5 μ l of Power SyBR Green (Applied Biosystems, 
Carlsbad, California, USA), 2 μ l of each primer, 1.5 μ l of cDNA, and 9 μ l of H2O were loaded into a 96 well plate 
and PCR performed in a 7300 Real Time PCR System (Applied Biosystems, Carlsbad, California, USA). Results 
were calculated using the relative CT method. The fold increase or decrease was determined relative to controls 
after normalizing to β -actin as housekeeping gene.
Western blotting and immunoprecipitation. Total brains, hippocampi or cultured neurons were 
homogenized twice for 2 min using metallic beads at a frequency of 20 Hz in RIPA buffer (20 mM Tris-HCl, pH 
7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% NP-40, 1% NaDC, 2.5 mM Na4 P2O7, 1 mM b-glycerophosphate, 
1 mM Na3VO4, 1 μ g/ml leupeptin). Samples were kept on ice for 1 h followed by centrifugation at 13,000 rpm 
at 4 °C for 1 h. Proteins were immunoprecipitated from cleared lysates, containing protease inhibitor cocktail 
(AMRESCO, OH, USA), using anti-ubiquitinylated proteins antibody (5 μ g/ml) (clone FK2, mouse monoclonal 
IgG1, from Millipore, Darmstadt, Germany) for 4 hrs at 4 °C followed by incubation with protein G-conjugated 
sepharose (GE Healthcare, Little Chalfont, UK) for 1 h at 4 °C. Precipitates were rinsed three times with washing 
buffer (50 mM Tris/HCl, pH 7.4, 500 mM NaCl, 2 mM EDTA, 0.2% Igepal) for 10 min at 4 °C. Precipitates were 
collected by centrifugation (4,000× g, 4 °C, 5 min) and eluted by incubation with SDS sample buffer (25 mM Tris/
HCl, pH 6,8, 10% Glycerin, 1,5% SDS, 20 mM DTT) for 10 min at 95 °C. Samples were separated by SDS-PAGE 
and transferred on nitrocellulose membrane. The membrane was incubated with anti-synapsin-1 or anti-USP14 
primary antibody overnight at 4 °C. Lysates from total brain, hippocampus and cell cultures were also incubated 
with SDS sample buffer for 10 min at 95 °C. Proteins were separated by SDS-PAGE, images were cropped and 
quantified as described earlier4.
Immunocytochemistry. Coverslips with cerebellar neurons were washed with phosphate-buffered 
saline (PBS) and then fixed with 4% paraformaldehyde for 10 min. Then cells were permeabilized with 0.25% 
Triton-X100-PBS for another 10 min and blocked with 5% BSA in 0.125% Triton X-100 in PBS for 1 h. After 
blocking cells were incubated for 1 h with the primary antibody diluted in 2.5% BSA in 0.125% Triton X-100 
in PBS. Following washing with 0.125% Triton X-100 in PBS, cells were incubated with a mixture of second-
ary antibodies conjugated to Alexa Fluor 488, and Alexa Fluor 647 Phalloidin (1:20 in PBS) (for F-actin stain-
ing), and DAPI (1:1000 in PBS) for another hour. Reagents were obtained from Cell Signaling Technology 
(Cambridge, UK). After washing, coverslips were mounted on glass slides and stored at 4 °C in the dark until 
analysis. The slides were imaged using an LSM 710 Axio Observer confocal laser scanning microscope (Carl 
Zeiss, Oberkochen, Germany).
Proteasomal activity. Proteasomal activity was assessed using the Proteasome Activity Fluorometric 
Assay Kit, (BioVison, CA, USA). Proteasomal inhibitors epoxomycin and MG-132 were from Merck-Millipore 
(Darmstadt, Germany) and from Enzo Life Sciences (Loerrach, Germany), respectively.
Electrophysiological recordings. Electrophysiological recordings were performed in hippocampal slices 
from 2 to 12 months old mice. Slices of 300 μ m (whole cell recordings) or 400 μ m (field potential recordings) 
thickness were stored in artificial cerebrospinal fluid (ACSF) gassed with carbogen. Stimulation with biphasic 
pulses was provided by an A-M systems stimulator (2100, A-M Systems, Sequim, USA). Recording electrodes 
(3–8 MΩ) were pulled from borosilicate glass (Kimble Chase, Vineland, USA) and all electrophysiological 
measurements were performed using a HEKA EPC10 patch clamp amplifier and Patchmaster software (HEKA, 
Göttingen, Germany). Data were filtered and digitized at 3 and 50 kHz, respectively, and stored on hard disk. All 
experiments were performed at room temperature.
Field potential recordings. Dendritic field excitatory postsynaptic potentials (fEPSPs) were recorded from the 
stratum radiatum of CA1 in response to stimulation of Schaffer collateral axons using glass micropipettes (Kimble 
Chase Vineland, USA) filled with ACSF. The initial slope of fEPSPs was used as a measure of synaptic response. 
Stimulation was applied as paired pulses (interval 40–400 ms) at 0.06 Hz. In experiments where we studied LTP 
fEPSPs were collected at a rate of 0.06 Hz. Baseline values were collected for 10 min (0.06 Hz) prior to LTP which 
was induced by a 1 s stimulation at 100 Hz.
Measurements of miniature excitatory postsynaptic currents (mEPSCs). Whole-cell voltage-clamp recordings 
(WCR) from CA1 pyramidal cells were performed with patch pipettes filled with internal Cs-gluconate record-
ing solution containing (in mM): 100 Cs-gluconate, 0.6 EGTA, 5 MgCl2, 10 HEPES, 3 ATP, 0.3 GTP, 3 lido-
caine N-ethyl bromide, osmolarity: 290 mOsm, pH 7.3. Neurons were voltage-clamped at − 70 mV and mEPSCs 
recorded in 1 s blocks (sampling rate 80 μ s). Slices were perfused with ACSF recording solution supplemented 
with 1 μ M tetrodotoxin to prevent action potentials and 100 μ M picrotoxin to suppress inhibitory currents35. Data 
were collected for at least 15 minutes.
Measurements of release probability. WCR were performed in hippocampal CA1 pyramidal neurons. Excitatory 
postsynaptic currents (EPSCs) were elicited by stimulation of the CA3 Schaffer collaterals. Patch electrodes were 
filled with internal Cs-gluconate recording solution. Initial release probability was determined by measuring the 
rate of block of the NMDA EPSCs by the open channel blocker MK-801 (40 μ M) during stimulation at 0.05 Hz19,54. 
NMDA EPSCs were pharmacologically isolated using 10 μ M NBQX to block AMPA/kainate receptors, 100 μ M 
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picrotoxin to block GABAA-mediated inhibition and 10 μ M CGP55845 to block GABAB-mediated inhibition. 
Holding potential was − 40 mV.
After obtaining a stable baseline at 0.05 Hz stimulation MK-801 was washed in. Following a 10 min wash-in 
period with no stimulus, stimulation was resumed at 0.05 Hz and 80–100 EPSCs were recorded. The release prob-
ability of facilitated pulses was assayed in a similar manner. The rate of block was measured in response to 100 Hz 
3-pulse trains with a 20 s inter-train interval35. The NMDA receptor mediated response was quantified as charge 
transferred by the EPSCs and normalized to the initial response. A single exponential was fitted to the resulting 
decay curve. The decay constant (τ ) was obtained for each experiment.
Data analysis. Analysis of electrophysiological recordings was carried out offline using Patchmaster (HEKA) or 
IGOR software (Wavemetrics, Lake Oswego, OR, USA). Data fitting and statistical analysis was performed using 
GraphPad PRISM 5.0 (GraphPad Software Inc., San Diego, CA, USA). Detection of spontaneous mEPSC from 
records was performed using a threshold above baseline detector55 in Neuromatic analysis software (NeuroMatic 
Version 2.0, http://www.neuromatic.thinkrandom.com). We used a threshold of 3 standard deviations (SD) above 
the baseline as criterion to detect mEPSCs. For each trace average and SD of the baseline current was analyzed 
within a 10 ms segment. Since the aim was to characterize the mean properties of mEPSC in control and SPLfl/fl/Nes 
mice we pooled the mEPSC from all cells in each group. Frequency analysis of mEPSC amplitude and time inter-
val between events was performed. Results were plotted as relative cumulative frequency distribution with equal 
bin width (n = 100). Comparison of mEPSC frequency and mEPSC amplitude revealed significant differences 
between control and SPLfl/fl/Nesmice (unpaired Student’s t test, P < 0.001).
Electron microscopy. Animals (n = 3 per genotype) were perfused transcardially with 3% glutaraldehyde 
(Merck, Darmstadt, Germany) in Dulbecco’s PBS (DPBS; Gibco® ). Brains were dissected and post-fixed for 4 h at 
4 °C in the same fixative washed in DPBS and the hippocampus cut into 100 μ m in a vibratome (Leica, Germany). 
The sections were postfixed in 1% osmium tetroxide in 0.1 M cacodylate buffer (pH 7.4), dehydrated in ethanol, 
and embedded in Durcupan ACM resin (Fluka Chemicals, Gillingham, UK). Sections were stained en block with 
1% uranyl acetate in 70% ethanol. Serial ultrathin (70 or 100 nm) and semithin (2 μ m) sections were cut with a 
diamond knife (Diatome). Ultrathin sections were collected onto formvar-coated copper grids, counterstained 
with 2% uranyl acetate and lead citrate, and examined in a Tecnai 12 electron microscope (FEI) equipped with 
2kx2k TemCam-F224HD camera (TVIPS). Complete series of up to 100 ultrathin sections were used to follow 
cell morphology and synaptic terminals in 3-dimensions.
Quantification of EM data. Images were quantified using Image J software. SV density was calculated as the 
number of vesicles per square micrometer within regions outlined by 100 nm steps or 300 nm step from the 
active zone border. SV diameters were measured in 70 nm thick synapse sections. To measure SV diameters clear 
cut vesicles displaying distinct lipid bilayer were selected. Two measurements between the middle of the bilayer 
acquired at 90° were acquired for each vesicle and averaged. Number of coated vesicles and endosomal profiles 
found in nerve terminals were normalized to the length of the active zones acquired from the middle section of 
synapses. 50 nm thick sections were used to determine the number of docked vesicles in contact with the presyn-
aptic membrane per active zone area.
Behavioural Analysis. Mice (15–18-month old; n = 9 controls and n = 10 SPLfl/fl/Nes) were tested for explor-
atory locomotion behaviour, spatial learning, short-memory and motor coordination. All experiments were con-
ducted blind with respect to the genotype of the tested animals.
Open field. The test apparatus (ActiMot; TSE, Bad Homburg, Germany) was a transparent and infrared light–
permeable acrylic test box (45.5 cm × 45.5 cm × 39.5 cm internal measurements). Animals were allowed to freely 
explore the test arena for 20 minutes. An automated tracking system (Ethovision XT; Noldus, Wageningen, 
Netherlands) was used to record the total distance travelled by animals.
Object placement recognition. After handling and habituation to the empty test arena, mice were subjected to 
3 trials of 6-minute training session, during which they were allowed to explore freely 2 identical objects (small 
glass bottles) that were placed in defined locations of the test arena. Next day, a 6-minute test session was per-
formed, during which the position of one of the objects was changed, while the position of the other remained 
unaltered. An automated tracking system (Ethovision XT; Noldus) was used to monitor and record the behaviour 
of the animals. The time the animals spent exploring the object in the novel location and the known location 
during the test was hand-scored from video recordings.
Rotarod. An accelerating rotarod (Bioseb, Vitrolles, France) was used to measure motor coordination, balance, 
and motor learning abilities. Mice were placed on the rotarod, and the rod rotations were subsequently acceler-
ated from 4 to 40 rpm during the 5-minute trial period. Trials were terminated when animals fell off the rod or 
when 5 minutes had elapsed, whichever came first. Mice were given 3 trials every day with a 30 min inter-trial 
interval, for 4 consecutive days.
Statistical analysis. All values are presented as means ± SEM. Student’s t-test, Mann-Whitney U test and 
two-way ANOVA were used for statistical analysis of the data. Normality of datasets larger than seven was tested 
with D’Agostino and Person omnibus normality test. P values lower than 0.05 were considered significant. In the 
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figures asterisks indicate P values as follows: * < 0.05; ** < 0.01; *** < 0.001. The GraphPad Prism 5 software was 
used for statistical analysis.
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